NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.12
+0.11 (0.55%)
Nov 21, 2024, 4:00 PM EST - Market closed

NAMS Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
422.73340.45467.7360.387.86
Cash & Short-Term Investments
422.73340.45467.7360.387.86
Cash Growth
0.97%-27.21%674.64%668.09%-
Other Receivables
5.151.882.074.88-
Receivables
5.151.882.074.88-
Prepaid Expenses
104.468.181.71.36
Total Current Assets
437.87346.79477.9866.969.22
Property, Plant & Equipment
0.720.10.150.220.01
Other Intangible Assets
0.590.170.21--
Other Long-Term Assets
-0.040.16--
Total Assets
439.19347.1478.567.999.23
Accounts Payable
7.0416.9211.857.070.4
Accrued Expenses
10.5811.46.124.10.76
Short-Term Debt
----11.65
Current Portion of Leases
0.240.060.070.06-
Current Unearned Revenue
4.58.9413.87--
Other Current Liabilities
18.912.574.15--
Total Current Liabilities
41.2649.936.0611.2412.81
Long-Term Leases
0.27-0.060.13-
Long-Term Unearned Revenue
-1.024.79--
Other Long-Term Liabilities
18.817.797.52--
Total Liabilities
60.3358.748.4311.3612.81
Common Stock
11.4410.1710.060.130.05
Additional Paid-In Capital
829.4590.77555.6395.262.45
Retained Earnings
-466.39-316.97-140.04-39.44-6.08
Comprehensive Income & Other
4.424.424.420.67-
Shareholders' Equity
378.86288.39430.0756.63-3.58
Total Liabilities & Equity
439.19347.1478.567.999.23
Total Debt
0.510.060.130.1911.65
Net Cash (Debt)
422.22340.39467.660.19-3.79
Net Cash Growth
0.87%-27.21%676.83%--
Net Cash Per Share
4.694.1424.655.48-0.76
Filing Date Shares Outstanding
92.3989.2781.7711.335
Total Common Shares Outstanding
92.1782.4781.5611.335
Working Capital
396.62296.89441.9255.72-3.59
Book Value Per Share
4.113.505.275.00-0.72
Tangible Book Value
378.27288.22429.8656.63-3.58
Tangible Book Value Per Share
4.103.495.275.00-0.72
Machinery
---0.040.01
Source: S&P Capital IQ. Standard template. Financial Sources.